Mycenax Biotech (ROCO:4726) Short-Term Capital Lease Obligation : NT$31.8 Mil (As of Mar. 2025)

View and export this data going back to 2013. Start your Free Trial

What is Mycenax Biotech Short-Term Capital Lease Obligation?

Mycenax Biotech's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was NT$31.8 Mil.

Mycenax Biotech's quarterly Short-Term Capital Lease Obligation declined from Sep. 2024 (NT$35.0 Mil) to Dec. 2024 (NT$31.9 Mil) and declined from Dec. 2024 (NT$31.9 Mil) to Mar. 2025 (NT$31.8 Mil).

Mycenax Biotech's annual Short-Term Capital Lease Obligation declined from Dec. 2022 (NT$37.3 Mil) to Dec. 2023 (NT$30.6 Mil) but then increased from Dec. 2023 (NT$30.6 Mil) to Dec. 2024 (NT$31.9 Mil).

Mycenax Biotech Short-Term Capital Lease Obligation Historical Data

The historical data trend for Mycenax Biotech's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mycenax Biotech Short-Term Capital Lease Obligation Chart

Mycenax Biotech Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

24.33

28.59

37.28

30.57

31.92

Mycenax Biotech Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															36.37	33.84	34.99	31.92	31.78

Mycenax Biotech Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Mycenax Biotech Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Mycenax Biotech's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Mycenax Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mycenax Biotech Inc (ROCO:4726) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.66, Shengyi 2nd Road, 7th Floor, Hsinchu Science Park, Hsinchu County, Zhubei, TWN, 302041

Website

https://www.mycenax.com.tw

Mycenax Biotech Inc is a Taiwan-based biopharmaceutical company. It is engaged in the development and manufacture of biopharmaceutical products, specializing in mammalian and microbial cell-derived biologics. The company provides services for program evaluation/confirmation, cell line development, and construction, process development technology platforms, drug characterization analysis, the establishment of testing methods, and drug production in accordance with PIC/S GMP manufacturing standards.

Mycenax Biotech Headlines

No Headlines